title: Tuberculous hepatic abscess appearing after liver transplantation in a patient with human immunodeficiency virus and hepatitis B and C virus co-infection.
abstract: Tuberculosis infection occurs relatively frequently in solid organ transplant recipients, although the occurrence of tuberculous hepatic abscesses is uncommon. Anti-tuberculous therapy has several concerns in transplant recipients, including an increased risk of cellular rejection and potential hepatotoxicity. We present the case of a human immunodeficiency virus-infected liver transplant patient who developed multiple tuberculous liver abscesses. Treatment with isoniazid, ethambutol, pyrazinamide, and moxifloxacin was efficacious, well tolerated, and safe.
authors.affiliation: Department of Internal Medicine, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain. mrodfra@yahoo.es
authors.forename: M
authors.initials: M
authors.lastname: Rodríguez-Framil
authors.forename: A
authors.initials: A
authors.lastname: Antela
authors.forename: A
authors.initials: A
authors.lastname: Prieto
authors.forename: E
authors.initials: E
authors.lastname: Otero
authors.forename: E
authors.initials: E
authors.lastname: Molina
authors.forename: E
authors.initials: E
authors.lastname: Varo
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000008:administration & dosage / Q000627:therapeutic use; D015658:HIV Infections / Q000150:complications*; D006509:Hepatitis B / Q000150:complications*; D006526:Hepatitis C / Q000150:complications*; D006801:Humans; D008100:Liver Abscess / Q000188:drug therapy / Q000382:microbiology*; D008103:Liver Cirrhosis / Q000821:virology; D016031:Liver Transplantation; D008297:Male; D009169:Mycobacterium tuberculosis; D014376:Tuberculosis / Q000188:drug therapy*
chemical_list: D019380:Anti-HIV Agents; D000995:Antitubercular Agents